Welcome to The Long Term Forecast, hosted by Dr. Denise Milne, Executive Director of the Alberta Continuing Care Association (ACCA).
In this episode, Denise sits down with Dr. Scott Sugden to discuss enhancing respiratory health in long term care through molecular diagnostics testing. Dr. Sugden is an expert in human immunology, focused particularly on infectious disease and immuno-oncology.
This is the third and final episode in our respiratory illness series for the 2024 season. Listen back to episodes 2 and 3 for more information on respiratory health in continuing care.
A special thank you to Cepheid for sponsoring this episode.
Cepheid is a cutting-edge, global diagnostics company at the forefront of molecular diagnostic innovation. Renowned for their state-of-the-art technology, Cepheid delivers rapid and highly accurate testing solutions for a broad spectrum of conditions, including Flu, RSV, and Covid-19. Their groundbreaking system – the GeneXpert Xpress – acclaimed for its ease of use and reliability, is transforming patient care and public health at the point-of-care on a global scale.
Want to learn more?
- Visit the Long Term Care Canada website at https://www.simpler.cepheid.ca
- Reach out to Sarah at sarah.garringer@cepheid.com for specific inquiries.
- Read our blog: The Rise of Molecular Diagnostics in Long Term Care
About ACCA
The Alberta Continuing Care Association (ACCA) is a non-profit, voluntary organization, and the leading voice of continuing care in Alberta made up of a unique alliance of non-profit, faith-based, and private owners/operators of home care, supportive living, and long term care services, and providers of quality products and services that support continuing care.
Our Voice is Stronger Together.
Learn more at www.ab-cca.ca